Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $43.00 price target on the stock.
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Global Veterinary Ultrasound Research Report 2024: Market to Surpass $500 Million by 2030 - Focus on Improving Livestock Health in Emerging Countries Presents Untapped Growth Opportunities [Yahoo! Finance]Yahoo! Finance
- FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious' [Yahoo! Finance]Yahoo! Finance
- Urinary Catheters Market Size Set for Revenue Worth US$55 Billion by 2031, Says Fairfield Market Research [Yahoo! Finance]Yahoo! Finance
- UPDATE 1-FDA classifies recall of Boston Scientific device as 'most serious' [Yahoo! Finance]Yahoo! Finance
- Endoscopy Equipment Market is Expected to Reach $46.2 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 1/31/24 - Miss
BSX
Sec Filings
- 4/4/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- BSX's page on the SEC website